Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leuprorelin in Indolent Prostate Cancer
NCT02085252Phase 3Completed
- Sponsor
- Takeda
- Start
- Jun 2013
- Primary completion
- Nov 2016
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of leuprolide in prostate cancer (PCa), sponsored by Takeda. Started Jun 2013; status: completed.
02
Drugs
leuprolide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02085252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02085252.